Key result
Surgery plus adjuvant chemotherapy achieves 6-month metastasis-free survival in primary cardiac epithelioid angiosarcoma.
Why the study?
Primary cardiac angiosarcoma is an extremely rare, high-grade malignancy.
Case Report (n=1)
No
This case report describes an extremely rare presentation of primary cardiac epithelioid angiosarcoma in the left atrium wall.
Answers are grounded in this paper and cite their sources.
Supports multimodality therapy in rare cardiac angiosarcoma; leaves open optimal regimens and long-term outcomes.
Primary cardiac angiosarcoma is an extremely rare, high-grade malignancy. Here, we describe the case of a 44-year-old male patient with a heart tumor in the left atrium wall, which caused a large amount of pericardial effusion that invaded the surrounding area and is visible on transthoracic echocardiography, computed tomography, and magnetic resonance imaging. The postoperative histopathological results confirmed this case as a primary cardiac epithelioid angiosarcoma.
No takes yet. Share an insight, caveat, or question.
Hoa et al. (2022) conducted a case report in Primary cardiac epithelioid angiosarcoma (n=1). Surgical excision and adjuvant chemotherapy was evaluated. Surgical excision followed by adjuvant chemotherapy resulted in a remarkable recovery and 6-month metastasis-free survival in a 44-year-old male with primary cardiac epithelioid angiosarcoma.
Synapse has enriched 10 related papers. Consider them for comparative context: